• 1
    Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996; 125: 588598.
  • 2
    Poupon R. Autoimmune overlapping syndromes. Clin Liver Dis 2003; 7: 865878.
  • 3
    Woodward J, Neuberger J. Autoimmune overlap syndromes. HEPATOLOGY 2001; 33: 9941002.
  • 4
    Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. HEPATOLOGY 1998; 28: 296301.
  • 5
    Angulo P, El-Amin O, Carpenter HA, Lindor KD. Development of autoimmune hepatitis in the setting of long-standing primary biliary cirrhosis. Am J Gastroenterol 2001; 96: 30213027.
    Direct Link:
  • 6
    Colombato LA, Alvarez F, Cote J, Huet PM. Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis? Gastroenterology 1994; 107: 18391843.
  • 7
    Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. HEPATOLOGY 1998; 28: 360365.
  • 8
    Horsmans Y, Piret A, Brenard R, Rahier J, Geubel AP. Autoimmune chronic active hepatitis responsive to immunosuppressive therapy evolving into a typical primary biliary cirrhosis syndrome: a case report. J Hepatol 1994; 21: 194198.
  • 9
    Ohba K, Omagari K, Kusakari C, Kadokawa Y, Hayashida K, Takeshima F, et al. Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis. Dig Dis Sci 2005; 50: 201206.
  • 10
    Weyman RL, Voigt M. Consecutive occurrence of primary biliary cirrhosis and autoimmune hepatitis: a case report and review of the literature. Am J Gastroenterol 2001; 96: 585587.
    Direct Link:
  • 11
    Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929938.
  • 12
    Degott C, Zafrani ES, Callard P, Balkau B, Poupon RE, Poupon R. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. HEPATOLOGY 1999; 29: 10071012.
  • 13
    Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. HEPATOLOGY 1999; 29: 10781084.
  • 14
    Gheorghe L, Iacob S, Gheorghe C, Iacob R, Simionov I, Vadan R, et al. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease. Eur J Gastroenterol Hepatol 2004; 16: 585592.
  • 15
    Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. HEPATOLOGY 2002; 35: 409413.
  • 16
    Muratori L, Cassani F, Pappas G, Guidi M, Mele L, Lorenza V, et al. The hepatitic/cholestatic “overlap” syndrome: an Italian experience. Autoimmunity 2002; 35: 565568.
  • 17
    Suzuki Y, Arase Y, Ikeda K, Saitoh S, Tsubota A, Suzuki F, et al. Clinical and pathological characteristics of the autoimmune hepatitis and primary biliary cirrhosis overlap syndrome. J Gastroenterol Hepatol 2004; 19: 699706.
  • 18
    Talwalkar JA, Keach JC, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system. Am J Gastroenterol 2002; 97: 11911197.
    Direct Link:
  • 19
    Dufour JF, Zimmermann M, Reichen J. Severe autoimmune hepatitis in patients with previous spontaneous recovery of a flare. J Hepatol 2002; 37: 748752.
  • 20
    Nakamura K, Yoneda M, Yokohama S, Tamori K, Sato Y, Aso K, et al. Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis. J Gastroenterol Hepatol 1998; 13: 490495.
  • 21
    Duclos-Vallee JC, Di Martino V, Cazier A, Ballot E, Johanet C, Yamamoto AM, et al. Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids. Gastroenterol Clin Biol 2005; 29: 11731176.
  • 22
    Kanzler S, Bozkurt S, Herkel J, Galle PR, Dienes HP, Lohse AW. Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome) [in German]. Dtsch Med Wochenschr 2001; 126: 450456.
  • 23
    Vento S, Garofano T, Di Perri G, Dolci L, Concia E, Bassetti D. Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals. Lancet 1991; 337: 11831187.
  • 24
    Vento S, Guella L, Mirandola F, Cainelli F, Di Perri G, Solbiati M, et al. Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals. Lancet 1995; 346: 608609.
  • 25
    Vallone TM, Ditelberg J, Kaplan MM. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Dig Dis Sci 2005; 50: 167170.